A continued step forward in the treatment of epilepsy and the power of 3D printing. According to the Centers for Disease Control (CDC), there were 2.4 million adults living with active epilepsy in ...

MASON, Ohio, July 22, 2025 /PRNewswire/ -- Aprecia, the global leader in 3DP (three-dimensional print) technology for commercial-scale pharmaceutical manufacturing, today announced that the U.S. Food ...

The US Food and Drug Administration (FDA) has approved the first three-dimensional printed oral drug product, Spritam (levetiracetam), from Aprecia Pharmaceuticals, the company announced today.

These days, 3D printing seems poised to take over the world. You can 3D print prosthetic limbs, guns, cars, even houses. This month, another 3D printed product has hit the market, this one with ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

BLUE ASH, Ohio, Aug. 4 (UPI) --The U.S. Food and Drug Administration has approved the first 3-D printed pill, an epilepsy medication designed to be easier to swallow for adults with swallowing ...

An epilepsy treatment developed by Aprecia Pharmaceuticals has become the first drug made using 3D printing to be approved for marketing. The new drug – called Spritam (levetiracetam) – is a generic ...

It’s a development that could spell the end of horse pills, those large pharmaceuticals that seem impossible to swallow. Receive emails about upcoming NOVA programs and related content, as well as ...

DUBLIN--(BUSINESS WIRE)--The "3D Printed Drugs Market by Spritam (U.S. and Rest of World) and Other Drugs Potential Market by Scenario (Rapid Growth Scenario, Moderate Growth Scenario, and Low Growth ...